TECH Discloses Shareholder Lawsuit on Merger Proxy, Voluntarily Supplements Disclosures
· The NYC Memo
Bio-Techne Corporation disclosed a shareholder lawsuit, *Robert Garfield v. Baumgartner et al.*, filed September 9, 2026, alleging misrepresentations or omissions in the Proxy Statement for its merger with Merck KGaA. The company voluntarily supplemented certain disclosures in the Proxy Statement, including details on the 'Background of the Merger' and 'Opinion of Bio-Techne’s Financial Advisor' sections, to avoid potential delays or adverse effects on the merger.